Table 3.
Postoperative Outcomes
| Variable | Overall (n = 60) | SILSS Group (n = 20) | MPS Group (n = 40) | P value |
|---|---|---|---|---|
| Postoperative complication | 22 | 7 | 15 | 1.000 |
| Clavien I | 6 | 2 | 4 | 1.000 |
| Clavien II | 16 | 5 | 11 | 1.000 |
| Clavien III | 0 | 0 | 0 | 1.000 |
| Clavien IV | 0 | 0 | 0 | 1.000 |
| Bowel function (movement/gas)* | 2 (1–8) | 2 (1–2) | 2 (1–8) | .0446 |
| Oral intake* | 1 (1–6) | 1 (1–2) | 1.5 (1–6) | .0137 |
| Epidural out* | 3 (1–4) | 2 (2–4) | 3 (1–4) | .1673 |
| Need for NSAID | 24 | 7 | 17 | .7804 |
| Pain scores | ||||
| Max pain score day 1 (1–10) | 2.77 (0.65) | 2.40 (0.50) | 2.95 (0.64) | .0014 |
| Max pain score day 2 (1–10) | 2.08 (0.46) | 1.85 (0.49) | 2.2 (0.41) | .0047 |
| Max pain score day 3 (1–10) | 1.40 (0.53) | 1.55 (0.60) | 1.6 (0.50) | .7337 |
| Discharge* | 6.03 (±1.78) | 5.5 (±1.15) | 6.3 (±1.99) | .0536 |
| Readmission rate | 3 | 1 | 2 | 1.000 |
*
Days postoperatively.